Navigation Links
Watson Second Quarter 2011 Net Revenue Exceeds $1 Billion; Non-GAAP EPS of $1.01
Date:7/26/2011

in our Global Brands business, with R&D spending up 29 percent.  We also announced our acquisition of Specifar Pharmaceuticals, which brings not only additional earnings contribution, but also an expanded international platform for generic growth opportunities. In our Brand business, we announced an anticipated FDA action date for PROCHIEVE®, and shortly after the end of the quarter, entered into an exclusive licensing agreement with Antares Pharma, Inc. for a product that, if approved, will expand our position in the over-active bladder (OAB) market segment."

"We concluded the quarter with $245.0 million in borrowing capacity available on our revolving credit facility and our debt to adjusted EBITDA ratio remains favorable at 1.4x, affording us the ability to continue to pursue opportunities to expand Watson's businesses," concluded Bisaro. 

Business Segment ResultsGlobal Generics Segment InformationThree Months EndedJune 30,Six Months EndedJune 30,(Unaudited; $ in millions)

2011201020112010Product sales

$
781.5$
560.8$
,366.5$
,094.9Other revenue

10.910.226.019.9Net revenue

792.4571.01,392.51,114.8Operating expenses:Cost of sales

439.1305.9728.2593.4Research and development

58.344.6112.786.8Selling and marketing

37.727.568.354.4Segment contribution

$
257.3$
93.0$
483.3$
380.2Segment margin

32.5%33.8%34.7%34.1%Adjusted gross profit (1)

$
357.9$
277.3$
4.9$
550.4Adjusted gross margin

45.2%48.6%48.0%49.4%(1) Adjusted gross profit represents adjusted net revenue less adjusted cost of sales and excludes amortization of acquired intangibles. Pro forma adjustments for the respective periods include the following: Settlement of contingent asset acquired as part of a business combination

$
-$
-$
(7.4)$
-Operational Excellence Initiative

1.912.25.317.2Purchase accounting adjustments

2.7-2.7
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Watson Confirms JALYN™ Patent Challenge
2. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
3. Watson Confirms Vyvanse® Patent Challenge
4. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings
5. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
6. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
7. Watson Confirms AVODART(R) Patent Challenge
8. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
9. Watsons Nabumetone Tablets Receive FDA Approval
10. Watson Confirms Pataday™ Patent Challenge
11. Watson Confirms Viagra® Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Diseases largely eradicated in ... returning. Measles was declared eliminated in 2000, yet the ... August 15—the highest incidence in 20 years. In July, ... whooping cough a problem of "epidemic proportions." ... dying from these preventable diseases—in part because some parents ...
(Date:8/29/2014)... , Aug. 29, 2014  In part ... to leverage a hospital pharmacy as a strategic asset, ... national practice leader for Cardinal Health,s Innovation Delivery Solutions ... care can benefit both hospitals and patients. ... only one part of their job in a value-based ...
(Date:8/29/2014)... 29, 2014 Pixcelldata, the innovative ... has announced a major new deal with Dutch based ... pathology expert, Dr. Marius Nap . ... European Congress of Pathology which is taking placing between ... London where Pixcelldata will demonstrate ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2
(Date:8/29/2014)... 29, 2014 Carson Hearing Care has ... hearing health care tips to local residents on a ... will offer weekly articles from the audiologists at Carson ... the latest advances in hearing restoration research, new tinnitus ... audiologists plan to write a new post on the ...
(Date:8/29/2014)... NEW YORK August 29, 2014 - Despite US ... obesity, there are many barriers, several of which may ... study by researchers at NYU Langone Medical Center published ... General Internal Medicine ( JGIM ). , David ... Department of Internal Medicine at NYU Langone, and colleagues ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 ... poised to begin accepting applications next month for ... are transitioning into accepting marijuana as a legalized ... and dispensaries will be permitted to operate in ... communities will be best suited to handle legal ...
(Date:8/29/2014)... August 29, 2014 The microbiology testing ... the in-vitro diagnostics industry; it is also the hugest ... driven by the ongoing spread of AIDS – still ... associated with the upsurge of opportunistic infections (OIs); bioterrorism ... broader availability of immunosuppressive medicines. Although for certain infections ...
(Date:8/29/2014)... 29, 2014 Floors of hospitals and ... wearing socks. Also, many patients are relegated to lying ... surgery recovery, Alzheimer’s, etc. Two inventors from Perrysburg, Ohio, ... patient safety. , This special pair of socks helps ... keeps patients who are relegated to beds or chairs ...
Breaking Medicine News(10 mins):Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Options for weight loss your primary care doctor might not know about 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3
... 27 The Ensign,Group, Inc. (Nasdaq: ENSG ... of,skilled nursing, rehabilitative care services and assisted living,companies, ... FBR Capital,Markets 12th Annual Spring Investor Conference on ... York City. Christopher Christensen, CEO, together with Alan,Norman, ...
... E-Connect Statewide to Discuss Successes and Challenges, ... million children,in California experience an emotional or behavioral ... receive adequate treatment. A lack of knowledge,stigma, limited ... and treatment, putting children at risk for school ...
... Healthcare Consulting Team, ANNAPOLIS, Md., May 27 ... leader in the case management field, has joined ... Ms. Craig, architect of the best-in-class caseload,workflow application, ... Mr. Garry Carneal, SHS President and CEO. "Kathy ...
... disease, study says , , TUESDAY, May 27 (HealthDay News) -- ... even in nonsmokers, researchers report. , The findings -- that ... developing lung cancer, regardless of whether he or she ever ... disease, said study author Dr. Ping Yang, of the Mayo ...
... Kevin Hutchinson to Inaugural Board of Managers, ... chief,executive officer, Kevin Hutchinson, has been named an ... LLC, a wholly owned subsidiary of the,American Academy ... consulting services to primary care physicians and health,systems ...
... Calif., May 27 Animal Dermatology Clinic (ADC),Tustin announces ... the new,Member-At-Large on the Executive Board of the American ... ACVD oversees the,operation of and is the decision making ... term. The Member-at-Large position entails Dr.,Muse being a liaison ...
Cached Medicine News:Health News:The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 2Health News:The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th 3Health News:Techno-Savvy Public Awareness Campaign Enables Families to Send a Powerful Message About Children's Mental Health 2Health News:Acuity Workflow Solutions(TM) Enhances Medical Case Management Process: 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 3Health News:Prematics CEO Joins Initiative to Advance More Coordinated, Connected Health Care 2Health News:Prematics CEO Joins Initiative to Advance More Coordinated, Connected Health Care 3Health News:Animal Dermatology Clinic Tustin Announces Dr. Russell Muse's Appointment as the Member-At-Large for the Executive Board of the American College of Veterinary Dermatology 2
The Trans-Blot transfer cell, used with the included PowerPac 200 power supply, performs efficient, high-intensity electrophoretic transfers. The Trans-Blot cell offers many advantages....
... for a Range of ... Native Enzyme, High Intensity, ... Faster, Higher-Efficiency Transfers via ... Field-Intensity Transfers with Movable ...
... Includes: Criterion cell for running ... with plate electrodes. A blotter fit ... Criterion precast gel system, the Criterion ... the flexibility of the Trans-Blot system ...
A blotter fit for use with the incredible new Criterion precast gel system, the Criterion blotter combines excellent blotting efficiency with the flexibility of the Trans-Blot system and the ease-of-...
Medicine Products: